Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Vitura Health's share price for the quarter that ended in Dec. 2023 was A$0.255. Vitura Health's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 575.9 Mil. Therefore, Vitura Health's market cap for the quarter that ended in Dec. 2023 was A$146.8 Mil.
Vitura Health's quarterly market cap
declined
from Dec. 2022 (A$325.6 Mil) to Jun. 2023 (A$286.6 Mil) and
declined
from Jun. 2023 (A$286.6 Mil) to Dec. 2023 (A$146.8 Mil).
Vitura Health's annual market cap
increased
from Jun. 2021 (A$13.5 Mil) to Jun. 2022 (A$137.7 Mil) and
increased
from Jun. 2022 (A$137.7 Mil) to Jun. 2023 (A$286.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Vitura Health's Enterprise Value for Today is A$52.6 Mil.
Vitura Health Market Cap Historical Data
The historical data trend for Vitura Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vitura Health's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Vitura Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitura Health's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vitura Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Vitura Health's Market Cap falls into.
Vitura Health Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Vitura Health's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitura Health (ASX:VIT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Vitura Health Market Cap Related Terms
Thank you for viewing the detailed overview of Vitura Health's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has three business segments namely, the Medical segment, which involves the sale of medicinal cannabis products; the Clinics segment, which involves the operation of medicinal cannabis clinics; and the Consumer segment, which involves the sale of consumer (non-medical) products in Australia and previously in Asia. The company generates the majority of its revenue from the Medical segment. Geographically the company generates the majority of its revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:VIT has been successfully added to your 